an association between increasing short-term glycaemic variability and an additional risk of micro-or macrovascular complications has so far proved to be elusive. Retrospective data analyses of the Diabetes Control and Complications Trial (DCCT) have shown little signal that within-day variability is important in the development of microvascular complications .
However, this study was not originally designed to address this question.
Although postprandial hyperglycaemia (a subset of glucose variability) is generally regarded as a risk marker for cardiovascular disease [5], the only prospective study to specifically assess whether reducing within-day glycaemia might influence cardiovascular events has been unable show any benefit [6].
E. S. Kilpatrick (*)
Department of Clinical Biochemistry, Hull Royal Infirmary,
5)Contributions of basal and post-prandial hyperglycaemia to micro- and macrovascular complications in people with type 2 diabetes
http://www.ncbi.nlm.nih.gov/pubmed/16004665
Diabetologia (2012) 55:2089–2091
DOI 10.1007/s00125-012-2610-5